Edition:
United Kingdom

Nordic Nanovector ASA (NANOV.OL)

NANOV.OL on Oslo Stock Exchange

51.35NOK
19 Oct 2018
Change (% chg)

kr0.15 (+0.29%)
Prev Close
kr51.20
Open
kr51.50
Day's High
kr51.50
Day's Low
kr50.00
Volume
84,579
Avg. Vol
186,131
52-wk High
kr95.05
52-wk Low
kr37.26

Latest Key Developments (Source: Significant Developments)

Nordic Nanovector Q2 Loss Nok 82.9 Million
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - Nordic Nanovector ASA ::Q2 LOSS NOK 82.9 MILLION VERSUS LOSS NOK 66.3 MILLION YEAR AGO.REVENUES FOR Q2 AMOUNTED TO NOK 0 (NOK 0.1 MILLION).TOTAL OPERATING EXPENSES FOR Q2 WERE NOK 84.5 MILLION (NOK 76.3 MILLION).COMPREHENSIVE LOSS FOR Q2 AMOUNTED TO NOK 82.9 MILLION (LOSS OF NOK 66.3 MILLION).  Full Article

Nordic Nanovector Appoints Eduardo Bravo CEO
Monday, 25 Jun 2018 

June 25 (Reuters) - Nordic Nanovector ASA ::NORDIC NANOVECTOR APPOINTS EDUARDO BRAVO AS CHIEF EXECUTIVE OFFICER.MR BRAVO WILL TAKE UP CEO POSITION IN NORDIC NANOVECTOR ON 2 JULY AND WILL BE BASED IN LONDON, UK..BRAVO IS CURRENTLY CHAIRMAN OF VIVET THERAPEUTICS.  Full Article

Nordic Nanovector Updates On Clinical Trial Applications For Archer-1 And Paradigme Trials In Norway
Friday, 25 May 2018 

May 25 (Reuters) - Nordic Nanovector ASA ::NORDIC NANOVECTOR UPDATES ON CLINICAL TRIAL APPLICATIONS FOR ARCHER-1 AND PARADIGME TRIALS IN NORWAY.NORDIC NANOVECTOR - FEEDBACK FROM REK HAS BEEN RECEIVED FOLLOWING REVIEW OF CTA FOR ARCHER-1, WHICH TOOK PLACE ON 26 APRIL.IS TARGETING DOSING OF FIRST PATIENT IN SECOND HALF OF 2018.NORDIC NANOVECTOR - CTA FOR PARADIGME PHASE 2B TRIAL WAS ALSO REVIEWED BY REK ON 26 APRIL AND ITS DECISION IS STILL PENDING.  Full Article

Nordic Nanovector: Ludvik Sandnes To Step Down As Chairman
Tuesday, 8 May 2018 

May 8 (Reuters) - Nordic Nanovector ASA ::LUDVIK SANDNES HAS INFORMED THE NOMINATION COMMITTEE THAT HE WISHES TO STEP DOWN AS CHAIRMAN.THE NOMINATION COMMITTEE PROPOSES THAT LUDVIK SANDNES IS RE-ELECTED AS CHAIRMAN OF THE BOARD UNTIL A NEW CHAIRPERSON HAS BEEN ELECTED.THE ANNUAL GENERAL MEETING OF NORDIC NANOVECTOR ASA WILL BE HELD ON 30 MAY.  Full Article

‍Nordic Nanovector Provides Update On Paradigme Clinical Trial​
Wednesday, 4 Apr 2018 

April 4 (Reuters) - Nordic Nanovector ASA ::‍NORDIC NANOVECTOR PROVIDES UPDATE ON PARADIGME CLINICAL TRIAL​.‍RESULTS FROM PARADIGME ARE TARGETED FOR 1H 2020 (PREVIOUSLY 2H 2019) AND FIRST REGULATORY FILING IN 2020.‍GUIDANCE IS UNCHANGED FOR PREVIOUSLY REPORTED MILESTONES FOR ARCHER-1 AND LYMRIT 37-05, BOTH ANTICIPATED IN 2H 2018​.FINANCIAL RESOURCES ARE EXPECTED TO BE SUFFICIENT TO REACH DATA READ-OUT FROM PARADIGME​.  Full Article

‍Nordic Nanovector Says Luigi Costa Will Step Down As CEO
Wednesday, 4 Apr 2018 

April 4 (Reuters) - Nordic Nanovector ASA ::‍NORDIC NANOVECTOR ANNOUNCES THAT LUIGI COSTA WILL STEP DOWN AS CHIEF EXECUTIVE OFFICER​.NORDIC NANOVECTOR ASA SAYS ‍COSTA HAS AGREED TO BE AVAILABLE TO BOARD UNTIL END OF JULY 2018​.  Full Article

Nordic Nanovector Q3 comprehensive loss widens to NOK 85.9 mln​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - NORDIC NANOVECTOR ASA ::‍REVENUES FOR Q3 AMOUNTED TO NOK 0.1 MILLION (NOK 0.1 MILLION)​.‍TOTAL OPERATING EXPENSES FOR Q3 WERE NOK 72.7 MILLION (NOK 50.4 MILLION)​.‍COMPREHENSIVE LOSS FOR Q3 AMOUNTED TO NOK 85.9 MILLION (LOSS OF NOK 61.3 MILLION)​.  Full Article

NORWEGIAN STOCKS-Shares lower despite higher oil prices, Kongsberg Gr jumps after Q2 earning

OSLO, Aug 24 (Reuters) - * Norwegian shares traded down on Friday * Oslo's benchmark index fell 0.23 pct, or 2.05 points, to 904.32 points and was up by 11.29 pct year-to-date * The broader Oslo All Share Index was down 0.15 percent * Brent crude futures, a trigger for the oil heavy Oslo Bourse, rose $0.54 to $75.27 a barrel * Among the biggest firms on the Oslo Bourse, Equinor fell 0.74 pct, Telenor fell 0.06 pct and DNB rose 0.41 pct * Turnover at the Oslo Bourse was 1.3 billion Norwegian crow